|
![]() |
|||
|
||||
OverviewBile acids have recently found application in the treatment of hepatobiliary diseases. Chenodeoxycholic acid and ursodeoxycholic acid have proved to be effective agents for the dissolution of cholesterol gallstones, and ursodeoxycholic acid has been shown to have beneficial effects in patients with chronic cholestatic liver disease such as primary biliary cirrhosis or primary sclerosing cholangitis. The question of the long-term benefit for the patient remains open and the mechanism of action is still unclear. As a consequence, much basic and clinical research is being conducted on bile acid therapy. The XIIth International Bile Acid Meeting brought together researchers and clinicians from around the world, and was dedicated to basic and clinical aspects of the use of bile acids in the therapy of hepatobiliary disease. Full Product DetailsAuthor: G. Paumgartner , A. Stiehl , W. GerokPublisher: Springer Imprint: Springer Edition: 1993 ed. Volume: 68 Weight: 0.735kg ISBN: 9780792388296ISBN 10: 0792388291 Pages: 384 Publication Date: 30 June 1993 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Out of Print Availability: Out of stock ![]() Table of ContentsPreface. Adolf Windaus Award 1992. Adolf Windaus Prize Lecture. Section I: Bile acid synthesis and metabolism. Section II: Bile acid transport. Section III: Hepatocellular effects of ursodeoxycholic acid. Section IV: Ursodeoxycholic acid therapy in hepatobiliary disease.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |